In the highly regulated and competitive biopharmaceutical industry, legal innovation is a critical driver of business success, guiding research and development (R&D), and matters of intellectual property (IP). Innovation in IP law is especially vital for a company like AbbVie, which has been at the forefront of R&D since its inception in 2013, investing almost $50 billion to advance and deliver new medicines.
To best serve our patients, researchers and partners, we have assembled a team of outside counsel from the top global law firms to help us navigate the legal complexities of developing solutions for the world’s toughest health challenges.